[go: up one dir, main page]

CN111166871A - 一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法 - Google Patents

一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法 Download PDF

Info

Publication number
CN111166871A
CN111166871A CN202010052179.0A CN202010052179A CN111166871A CN 111166871 A CN111166871 A CN 111166871A CN 202010052179 A CN202010052179 A CN 202010052179A CN 111166871 A CN111166871 A CN 111166871A
Authority
CN
China
Prior art keywords
parts
cranberry
collagen
effervescent tablet
borneol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010052179.0A
Other languages
English (en)
Inventor
赵丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010052179.0A priority Critical patent/CN111166871A/zh
Publication of CN111166871A publication Critical patent/CN111166871A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明属于生物制剂技术领域，特别是涉及一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法。包括以下质量配比的组分制成，蔓越莓9‑15份、水解胶原蛋白0.2‑2份、苦参6‑9份、血竭4‑10份、僵蚕3‑11份、黄柏3‑7份、蛇床子3‑10份、红花3‑8份、冰片0.1‑0.5份、醋酸氯己定0.1份—0.2份。抑菌效果更好，携带更加方便，制备工艺更加简单，具有更好的抗氧化能力，有效防止细胞受损。

Description

一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法
技术领域
本发明属于生物制剂技术领域，特别是涉及一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法。
背景技术
生物制剂抑菌自助外用泡腾片和普通药片不同，需要放在水中溶解后再外用。消杀药疗效果非常好，十分受欢迎。药剂工程师最近一直在研制这样一种剂型，希望它溶解度高、外用方便、起效更快。恰恰促成了这一剂型的诞生！将酸性物质(如柠檬酸)和碱性物质(苏打)适当比例作为辅料调配制剂，遇到水后就能产生大量气泡(二氧化碳)，并迅速溶于水中，这水便有了很强的消杀药效。
发明内容
本发明提供了一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法。
为了实现上述发明目的，本发明实施例提供了一种蔓越莓胶原蛋白草本抑菌泡腾圆片，包括以下质量配比的组分制成，蔓越莓9-15份、水解胶原蛋白0.2-2份、苦参6-9份、血竭4-10份、僵蚕3-11份、黄柏3-7份、蛇床子3-10份、红花3-8份、冰片0.1-0.5份、醋酸氯己定0.1份—0.2份。
进一步的，所述蔓越莓胶原蛋白草本抑菌泡腾圆片，包括以下质量配比的组分制成，蔓越莓9份、水解胶原蛋白0.2份、苦参6份、血竭4份、僵蚕3份、黄柏3份、蛇床子3份、红花3份、冰片0.1份、醋酸氯己定0.1份。
进一步的，所述蔓越莓胶原蛋白草本抑菌泡腾圆片，包括以下质量配比的组分制成，蔓越莓11份、水解胶原蛋白0.5份、苦参9份、血竭8份、僵蚕6份、黄柏6份、蛇床子5份、红花4份、冰片0.2份、醋酸氯己定0.2份。
进一步的，所述蔓越莓胶原蛋白草本抑菌泡腾圆片，包括以下质量配比的组分制成，蔓越莓15份、水解胶原蛋白2份、苦参9份、血竭10份、僵蚕11份、黄柏7份、蛇床子10份、红花8份、冰片0.5份、醋酸氯己定0.2份。
本发明实施例的另一方面，还提供了一种制备蔓越莓胶原蛋白草本抑菌泡腾圆片的方法，包括以下步骤，(1)将蔓越莓、苦参、蛇床子、红花、血竭、黄柏、僵蚕七味中药分别用8倍量、6倍量的蒸馏水煎煮两次，第一次2小时，第二次1.5小时，分别过滤，合并滤液；(2)将上述合并后的滤液真空浓缩成相对密度为1.05左右的清膏，备用；(3)在上述清膏中加入凝胶赋形剂，在均质机中制成凝胶剂；(4)最后依次加入水解胶原蛋白、冰片、醋酸氯己定，继续均质半小时，抽真空即可；(5)将配制好的凝胶用全自动凝胶灌装机灌装，3.5g/支包装。
本发明相比现有技术的有益效果是：本发明实施例所述的蔓越莓胶原蛋白草本抑菌泡腾圆片，抑菌效果更好，携带更加方便。
具体实施方式
在本发明实施例的描述中，除非另有说明，“多个”的含义是指两个或两个以上。例如，多个元件是指两个元件或两个以上元件。
本文中术语“和/或”，是一种描述关联对象的关联关系，表示可以存在三种关系，例如，显示面板和/或背光，可以表示：单独存在显示面板，同时存在显示面板和背光，单独存在背光这三种情况。本文中符号“/”表示关联对象是或者的关系，例如输入/输出表示输入或者输出。
在本发明实施例中，“示例性的”或者“例如”等词用于表示作例子、例证或说明。本发明实施例中被描述为“示例性的”或者“例如”的任何实施例或设计方案不应被解释为比其它实施例或设计方案更优选或更具优势。确切而言，使用“示例性的”或者“例如”等词旨在以具体方式呈现相关概念。
本发明实施例提供了一种蔓越莓胶原蛋白草本抑菌泡腾圆片，包括以下质量配比的组分制成，蔓越莓9份、水解胶原蛋白0.2份、苦参6份、血竭4份、僵蚕3份、黄柏3份、蛇床子3份、红花3份、冰片0.1份、醋酸氯己定0.1份。
示例性的，所述蔓越莓胶原蛋白草本抑菌泡腾圆片，包括以下质量配比的组分制成，蔓越莓11份、水解胶原蛋白0.5份、苦参9份、血竭8份、僵蚕6份、黄柏6份、蛇床子5份、红花4份、冰片0.2份、醋酸氯己定0.2份。
示例性的，所述蔓越莓胶原蛋白草本抑菌泡腾圆片，包括以下质量配比的组分制成，蔓越莓15份、水解胶原蛋白2份、苦参9份、血竭10份、僵蚕11份、黄柏7份、蛇床子10份、红花8份、冰片0.5份、醋酸氯己定0.2份。
本发明实施例的另一方面，还提供了一种制备蔓越莓胶原蛋白草本抑菌泡腾圆片的方法，包括以下步骤，首先将蔓越莓、苦参、蛇床子、红花、血竭、黄柏、僵蚕七味中药分别用8倍量、6倍量的蒸馏水煎煮两次，第一次2小时，第二次1.5小时，分别过滤，合并滤液；接下来，将上述合并后的滤液真空浓缩成相对密度为1.05左右的清膏，备用；然后在上述清膏中加入凝胶赋形剂，在均质机中制成凝胶剂；最后依次加入水解胶原蛋白、冰片、醋酸氯己定，继续均质半小时，抽真空即可；将配制好的凝胶用全自动凝胶灌装机灌装，3.5g/支包装。本发明实施例所述的蔓越莓胶原蛋白草本抑菌泡腾圆片，抑菌效果更好，携带更加方便，制备工艺更加简单，具有更好的抗氧化能力，有效防止细胞受损。
上面对本发明的实施例进行了描述，但是本发明并不局限于上述的具体实施方式，上述的具体实施方式仅仅是示意性的，而不是限制性的，本领域的普通技术人员在本发明的启示下，在不脱离本发明宗旨和权利要求所保护的范围情况下，还可做出很多形式，均属于本发明的保护之内。

Claims (5)

1.一种蔓越莓胶原蛋白草本抑菌泡腾圆片，其特征在于：包括以下质量配比的组分制成，蔓越莓9-15份、水解胶原蛋白0.2-2份、苦参6-9份、血竭4-10份、僵蚕3-11份、黄柏3-7份、蛇床子3-10份、红花3-8份、冰片0.1-0.5份、醋酸氯己定0.1份—0.2份。
2.一种蔓越莓胶原蛋白草本抑菌泡腾圆片，其特征在于：包括以下质量配比的组分制成，蔓越莓9份、水解胶原蛋白0.2份、苦参6份、血竭4份、僵蚕3份、黄柏3份、蛇床子3份、红花3份、冰片0.1份、醋酸氯己定0.1份。
3.一种蔓越莓胶原蛋白草本抑菌泡腾圆片，其特征在于：包括以下质量配比的组分制成，蔓越莓11份、水解胶原蛋白0.5份、苦参9份、血竭8份、僵蚕6份、黄柏6份、蛇床子5份、红花4份、冰片0.2份、醋酸氯己定0.2份。
4.一种蔓越莓胶原蛋白草本抑菌泡腾圆片，其特征在于：包括以下质量配比的组分制成，蔓越莓15份、水解胶原蛋白2份、苦参9份、血竭10份、僵蚕11份、黄柏7份、蛇床子10份、红花8份、冰片0.5份、醋酸氯己定0.2份。
5.一种制备上述权利要求1-4中任一所述蔓越莓胶原蛋白草本抑菌泡腾圆片的方法，其特征在于：包括以下步骤，(1)将蔓越莓、苦参、蛇床子、红花、血竭、黄柏、僵蚕七味中药分别用8倍量、6倍量的蒸馏水煎煮两次，第一次2小时，第二次1.5小时，分别过滤，合并滤液；(2)将上述合并后的滤液真空浓缩成相对密度为1.05左右的清膏，备用；(3)在上述清膏中加入凝胶赋形剂，在均质机中制成凝胶剂；(4)最后依次加入水解胶原蛋白、冰片、醋酸氯己定，继续均质半小时，抽真空即可；(5)将配制好的凝胶用全自动凝胶灌装机灌装，3.5g/支包装。
CN202010052179.0A 2020-01-17 2020-01-17 一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法 Pending CN111166871A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010052179.0A CN111166871A (zh) 2020-01-17 2020-01-17 一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010052179.0A CN111166871A (zh) 2020-01-17 2020-01-17 一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法

Publications (1)

Publication Number Publication Date
CN111166871A true CN111166871A (zh) 2020-05-19

Family

ID=70648010

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010052179.0A Pending CN111166871A (zh) 2020-01-17 2020-01-17 一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法

Country Status (1)

Country Link
CN (1) CN111166871A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113546122A (zh) * 2021-08-23 2021-10-26 徐州籽苑生物科技有限公司 一种多效养护抑菌软凝胶

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006081743A1 (fr) * 2005-02-06 2006-08-10 Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co., Ltd Medicament destine au traitement de l'erosion cervicale et procede de preparation de celui-ci
CN110464811A (zh) * 2019-09-18 2019-11-19 西安新君力生物科技有限公司 一种妇科用泡沫抑菌液及其制备方法
CN110559427A (zh) * 2019-10-28 2019-12-13 田兰 一种促进女性生殖系统排毒的中药生物制剂及其制备方法
CN110613839A (zh) * 2019-10-28 2019-12-27 田兰 一种作用于女性生殖系统的中药生物制剂及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006081743A1 (fr) * 2005-02-06 2006-08-10 Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co., Ltd Medicament destine au traitement de l'erosion cervicale et procede de preparation de celui-ci
CN110464811A (zh) * 2019-09-18 2019-11-19 西安新君力生物科技有限公司 一种妇科用泡沫抑菌液及其制备方法
CN110559427A (zh) * 2019-10-28 2019-12-13 田兰 一种促进女性生殖系统排毒的中药生物制剂及其制备方法
CN110613839A (zh) * 2019-10-28 2019-12-27 田兰 一种作用于女性生殖系统的中药生物制剂及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
闫向前 等: "晟洁芙克草本抑菌凝胶治疗泌尿生殖道支原体衣原体感染疗效观察", 《国外医学医学地理分册》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113546122A (zh) * 2021-08-23 2021-10-26 徐州籽苑生物科技有限公司 一种多效养护抑菌软凝胶

Similar Documents

Publication Publication Date Title
CN102205000B (zh) 一种裸花紫珠提取物及其制备方法和用途
CN101273960B (zh) 药物牙膏
CN111135292A (zh) 一种重组私密胶原蛋白肽护理抑菌凝胶及其制备方法
CN103340797A (zh) 积雪草提取物在中药牙膏中的应用
CN111803542A (zh) 一种生发中药组合物及其制备方法和应用
CN105232725A (zh) 一种祛痘配方及其制备方法
US9993510B2 (en) Acne-removing traditional chinese medicine composition and preparation method thereof
CN111358939A (zh) 一种用于促进女性生殖道修复的中药制剂及其制备方法
CN111166871A (zh) 一种蔓越莓胶原蛋白草本抑菌泡腾圆片及其制备方法
CN109646471A (zh) 一种富含稀有人参皂苷的活化三七皂苷在制备口腔护理产品中的应用
CN101085006A (zh) 一种含葛根治疗心血管疾病的组合物及其制剂
CN101085047A (zh) 一种含何首乌治疗心血管疾病的组合物及其制剂
CN111068045A (zh) 一种重组胶原蛋白私密抑菌凝胶及其制备方法
CN1241610C (zh) 一种防治前列腺炎及前列腺增生的药物组合物及其制备方法
CN101085008A (zh) 一种含刺五加治疗心血管疾病的组合物及其制剂
CN1931309A (zh) 一种美容祛斑保健品及其制备方法
CN101085134A (zh) 一种含血竭治疗心血管疾病的组合物及其制剂
CN102068482B (zh) 紫景天总黄酮及其提取方法和药物用途
CN110522685A (zh) 一种多功效面膜及其制备方法
CN101085010A (zh) 一种含盐肤木治疗心血管疾病的组合物及其制剂
CN101085081A (zh) 一种含枳壳治疗心血管疾病的组合物及其制剂
AU2019101673A4 (en) Coptis chinensis acne-removing composition and its application
CN112972594A (zh) 一种治疗青春痘的膏剂及其制备方法
CN101085007B (zh) 一种含灯盏花治疗心血管疾病的组合物及其制剂
CN1736404A (zh) 板蓝根维生素c复方制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200519